& Finance Buzz
Good day, 360! Happy Friday!
Here are some of our top movers today. Make sure to join us in Market Masters this morning and please text “RAGE” to 1-(888) 404-5747 to get all of our latest HOT STOCK ideas! Be the best prepared trader on the Street!
FOCUS LIST🔎
VMAR – Up over 70% in the pre-market after announcing partnership with Calip Group to innovate HV marine battery packs
DTIL – Up over 30% in the pre-market after announcing complete clinical response in first infant dosed by partner iECURE in ongoing phase 1/2 clinical trial in Ornithine Transcarbamylase (OTC) Deficiency
IINN – Up over 24% in the pre-market after announcing its preparing production in response to spread of respiratory virus in China
The Sleep App That Forbes Rated 5 Stars 😱
The app Forbes said helps “users achieve high-quality sleep by creating and maintaining effective sleep routines” is back with new sounds and features!
Now featuring over 300 unique sounds to fall asleep to, a personalized sleep tracker and more. It’s no wonder over 65 million people have downloaded this app for better sleep.
Try it tonight 👇
HOTLIST🔥
VMAR – Up over 70% in the pre-market after announcing partnership with Calip Group to innovate HV marine battery packs
Vision Marine Technologies Inc. (VMAR) designs, develops, manufactures, sells, and rents electric boats in Canada, the United States, and internationally.
In the pre-market this morning, the company announced the establishment of a production line for custom cooling plates in partnership with Calip Group, a leader in high-tech welding processes. Under this collaboration, Calip Group will supply components that enhance the thermal management of Vision Marine’s high-voltage (HV) marine battery packs. These custom cooling plates are specifically tailored to meet the stringent demands of marine applications, with production slated to begin in 2025.
Vision Marine’s E-Motion™ Powerpacks remain at the forefront of high-voltage marine battery technology.
This development underscores Vision Marines’ commitment to delivering advanced, reliable, and practical solutions that foster the adoption of sustainable marine propulsion systems. This production agreement with Calip Group is yet another step toward meeting growing market demand for high-performance electric boating technologies.
Shares of VMAR traded up over 70% in the pre-market in reaction to the news.
The $2.52 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $2.80, $3, $3.20, $3.45, $3.60 and then the pre-market high at $3.69. Beyond that, $4.10 and $4.90 come into play.
Below $2.52, targets to the downside are $2.20, $2, $1.75 and then a gap fill at $1.52.
DTIL – Up over 30% in the pre-market after announcing complete clinical response in first infant dosed by partner iECURE in ongoing phase 1/2 clinical trial in Ornithine Transcarbamylase (OTC) Deficiency
Precision BioSciences, Inc. (DTIL) is an advanced gene editing company that develops in vivo gene editing therapies for gene edits, including gene elimination, insertion, and excision in the United States.
In the pre-market this morning, the company announced that its partner iECURE has reported clinical efficacy and safety data in the first patient dosed with ECUR-506 in the Phase 1/2 OTC-HOPE study.
Highlights include:
– Treatment with ECUR-506 resulted in a complete clinical response from three months post exposure to the end of study (six months post exposure)
– ECUR-506 was generally well tolerated with no significant clinical safety concerns
– Insertion of a functional OTC gene through ARCUS in vivo gene editing may provide lasting clinical benefit for children with OTC deficiency who are in dire need of effective treatments
Shares of DTIL traded up over 30% in the pre-market in reaction to the news.
The $5.53 area acted as support in the pre-market and will be an important level to watch. Above it, targets to the upside are $6, $6.30 and then the pre-market high at $7.44. Beyond that $7.65, $8 and $9 come into play.
Below $5.53, targets to the downside are $5.30, $5 and then a gap fill at $4.50.
*sponsored by Finance Buzz
Rare Unlimited Cash Back Match Turns Heads
-
0% intro APR helps ease credit card pressure.
-
Earn 5% cash back, doubled first year.
-
Get up to 10% cash back rewards!
IINN – Up over 24% in the pre-market after announcing its preparing production in response to spread of respiratory virus in China
Inspira Technologies Oxy B.H.N. Ltd. (IINN) is a specialty medical device company that engages in the research, development, manufacture, and marketing of proprietary life support technology for the treatment of acute respiratory failure.
In the pre-market this morning, the company announced that it is preparing for a potential production ramp-up of its INSPIRA™ ART100 device. This strategic readiness comes in light of the recent outbreak of human metapneumovirus (hMPV) in China, which has highlighted the growing need for advanced respiratory care technologies globally.
Inspira is already in discussions with leading providers in affected regions to evaluate demand for advance respiratory solutions and deployment of the INSPIRA™ ART100 device, ensuring rapid response capabilities in case of increased demand.
Shares of IINN traded up over 28% in the pre-market in reaction to the news.
The $1.08 area acted as support in the pre-market and will be an important level to watch.
Above it, targets to the upside are $1.20, $1.30, $1.43, $1.50, $1.60, $1.70 and then the pre-market high at $1.75.
Below $1.08, targets to the downside are $1, $0.95 and then $0.8750.
MARKET NEWS 📰
DISCLAIMER: To more fully understand any Ragingbull.com, LLC (“RagingBull”) subscription, website, application or other service (“Services”), please review our full disclaimer located at https://ragingbull.com/disclaimer
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. Any RagingBull Service offered is for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation, or be relied upon as personalized investment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision.
RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers’ trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment.
RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor (IA), or IA representative with the U.S. Securities and Exchange Commission, any state securities regulatory authority, or any self-regulatory organization. Employees, owners, and other service providers of https:// ragingbull. com or RagingBull.com LLC are paid in whole or in part by commission based on their sales of Services to subscribers.
RagingBull.com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements. In the event that any suit or action is instituted as a result of doing business with RagingBull. com, LLC and/or its affiliates or if any suit or action is necessary to enforce or interpret these Terms of Service, RagingBull. com, LLC shall be entitled to recover attorneys’ fees, costs and disbursements in addition to any other relief to which it may be entitled.
*Sponsored Content: If you purchase anything through a link in this email other than RagingBull services, you should assume that we have an affiliate relationship with the company providing the product or service that you purchase, and that we will be paid in some way. We recommend that you do your own independent research before purchasing anything. We believe in the companies we form affiliate relationships with, but please don’t spend any money on these products or services unless you believe they will help you achieve your goals.
WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services except possibly by advertisers in this email. However, Ragingbull.com, LLC, its owners, and its employees may purchase, sell, or hold long or short positions in securities of the companies mentioned in this communication.
